Evidence map›Paper›PMID 35370490›Full record

ArticleThe Yale journal of biology and medicine2022

Resveratrol Supplants Captopril's Protective Effect on Cardiac Remodeling in a Hypertension Model Elicited by Renal Artery Stenosis.

Carolina B A Restini, Arthur F E Garcia, Henrique M Natalin, Mariane F A Carmo, Vinicius F Nowicki, Elen Rizzi, Leandra N Z Ramalho

Open access · greenAbstract read
In one paragraph

Article in The Yale journal of biology and medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Cardiovascular Protective Effect ofAdvances in pharmacological and pharmaceutical sciences · 2024
    Article
  6. Resveratrol and Gut Microbiota Synergy: Preventive and Therapeutic Effects.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Carolina B A RestiniDepartment of Pharmacology & Toxicology, College of Osteopathic Medicine, Michigan State University, Clinton Township, MI, USA.
Arthur F E GarciaDepartment of Biotechnology, University of Ribeirao Preto, Ribeirão Preto-SP, Brazil.
Henrique M NatalinDepartment of Biotechnology, University of Ribeirao Preto, Ribeirão Preto-SP, Brazil.
Mariane F A CarmoDepartment of Biotechnology, University of Ribeirao Preto, Ribeirão Preto-SP, Brazil.
Vinicius F NowickiDepartment of Biotechnology, University of Ribeirao Preto, Ribeirão Preto-SP, Brazil.
Elen RizziDepartment of Biotechnology, University of Ribeirao Preto, Ribeirão Preto-SP, Brazil.
Leandra N Z RamalhoDepartment of Pathology and Legal Medicine, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto-SP, Brazil.
Universidade de Ribeirão Preto · BRMichigan State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HypertensionRenal Artery ObstructionAnimalsCaptoprilHumansMaleRatsRats, WistarResveratrolVentricular RemodelingCaptoprilResveratrolCaptoprilCardiac Remodeling and FibrosisOxidative StressRenin-Angiotensin System (RAS)Renovascular HypertensionResveratrol

Identifiers

PMID35370490
PMCPMC8961705
OpenAlexW4226524549

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.